0001669639-24-000001.txt : 20240311
0001669639-24-000001.hdr.sgml : 20240311
20240311162442
ACCESSION NUMBER: 0001669639-24-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanzone Virginia Ruth
CENTRAL INDEX KEY: 0001669639
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 24738358
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-03-07
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001669639
Sanzone Virginia Ruth
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
VP, General Counsel
0
Common Stock
2024-03-07
4
M
0
1073
0.0
A
5751
D
Common Stock
2024-03-07
4
F
0
587
105.39
D
5164
D
Common Stock
2024-03-07
4
M
0
6436
0.0
A
11600
D
Common Stock
2024-03-07
4
F
0
3529
105.39
D
8071
D
Common Stock
2024-03-08
4
S
0
3300
104.5722
D
4771
D
Common Stock
2024-03-08
4
M
0
2273
0.0
A
7044
D
Common Stock
2024-03-08
4
F
0
1246
104.52
D
5798
D
Common Stock
0.0
2024-03-07
4
M
0
1073
0.0
D
2023-03-07
2025-03-07
Common Stock
1073
1073
D
Common Stock
2024-03-08
4
A
0
9568
0.0
A
Common Stock
9568
9568
D
Performance Shares
0.0
2024-03-07
4
M
0
6436
0.0
D
2024-03-07
Common Stock
6436
0
D
Performance Shares
0.0
2024-03-08
4
M
0
2273
0.0
D
2023-03-08
2024-03-08
Common Stock
2273
0
D
These securities are Restricted Stock Units.
These Securities are Performance-based Restricted Stock Units (PRSU).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
There is neither a purchase price nor an exercise price for the Restricted Stock Units.
One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
These are restricted stock units that fully vest 3 years from the grant date.
There is neither a purchase price nor an exercise price for the PRSUs.
These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.
By: Paula Darbyshire, Attorney-in-fact For: Virginia Sanzone
2024-03-11